
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
May 07, 2026 05:50 am UTC| Health Governance
U.S. health authorities are closely tracking the aftermath of a hantavirus outbreak aboard the luxury cruise ship MV Hondius, which has already claimed three lives and raised international health concerns. The Centers for...

Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
May 06, 2026 08:19 am UTC| Business Health
Novo Nordisk A/S (NYSE: NVO) increased its full-year 2026 guidance after strong demand for its obesity and diabetes treatments continued to drive growth, despite ongoing pricing pressure in key markets. The Danish...

Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
May 03, 2026 01:06 am UTC| Business Law Health
Two major pharmaceutical companies, Danco Laboratories and GenBioPro, have petitioned the U.S. Supreme Court to restore nationwide mail-order access to mifepristone, a widely used abortion pill. The emergency request comes...

Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
May 02, 2026 02:34 am UTC| Health Politics Governance
U.S. President Donald Trump announced on Friday that the federal government is taking steps to expand access to GLP-1 medications for seniors enrolled in Medicare, with coverage expected to begin on July 1. This move could...

AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Apr 29, 2026 10:48 am UTC| Business Health
AstraZeneca reported robust first-quarter 2026 earnings, driven by strong demand for its oncology and rare disease treatments, delivering solid revenue growth and beating analyst expectations. The U.K.-based pharmaceutical...

Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Apr 24, 2026 03:57 am UTC| Business Health
Daiichi Sankyo shares tumbled sharply on Friday after the Japanese pharmaceutical company announced a delay in its annual earnings release, raising concerns among investors about its oncology business and potential...

Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Apr 24, 2026 03:19 am UTC| Business Health
Shares of womens healthcare company Organon Co (NYSE: OGN) climbed sharply in after-hours trading on Thursday following reports that India-based Sun Pharmaceutical Industries Ltd. (NSE: SUN) is preparing a $13 billion...